Idiopathic Anemia of Aging (IAA)

• Status: Terminated
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Aging (NIA)
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• 70 years of age or older

• Diagnosed with anemia

• Hemoglobin level less than or equal to 11

• Able to perform most activities of daily living without restriction

Exclusion Criteria:

• History of serious heart, liver or kidney disease

• Cancer treated within the last year except for skin cancer (excluding melanoma)

• Problems with your immune system

• Received Epoetin Alfa within the last year